{
  "docId": "019dd923-622c-750b-8b9a-21918ac10c17",
  "docSlug": "f3db2294dcf9",
  "documentTitle": "Harmony Biosciences (HRMY)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2023-03-28 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 10,
  "pageCount": 366,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 8,
  "notes": "The slide uses a structured list format to present three distinct areas of clinical concern, each with corresponding reference numbers.",
  "elementsJson": [
    "headline_text",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-21918ac10c17/10",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17#slide-10",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "FDA's sensitivity to potential CNS and hepatic safety signal will now be highly problematic for Harmony",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64d0-7099-9cc8-cfb1d115430e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.85,
        "x": 0.073,
        "y": 0.375
      },
      "kind": "list",
      "text": "Hypereosinophilic syndrome and drug-induced phospholipidosis overlooked by FDA. Pitolisant exhibits a clear and startling signal for hypereosinophilic syndrome, which we found buried in a single line...",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "053ade2b-77fa-4196-a14a-5d68e99113d7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.85,
        "x": 0.073,
        "y": 0.605
      },
      "kind": "list",
      "text": "FAERS database confirms a massive toxicity issue since pitolisant’s approval in 2019, including a recent fatality. The FDA Adverse Events Reporting System (FAERS) indicates a clear safety problem...",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b564e430-e240-4cf7-8de8-32af9eec4b1d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.073,
        "y": 0.195
      },
      "kind": "list",
      "text": "FDA’s sensitivity to potential CNS and hepatic safety signal will now be highly problematic for Harmony. In addition to cardiotoxicity, the FDA's review exhibited skittishness at CNS and hepatic issues...",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b9973bed-1b9a-4921-ade7-f4153d32934a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.65,
        "x": 0.073,
        "y": 0.128
      },
      "kind": "title",
      "text": "Part 2. Clinical evidence of pitolisant’s toxicity is overwhelming (cont'd)",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "097f948b-489d-4e32-8fbd-73107d03c4c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.37,
        "x": 0.073,
        "y": 0.073
      },
      "kind": "title",
      "text": "Executive summary (cont'd)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ae8c6a33-89e4-4fec-b717-fcb88b252e93",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "449d0109-dd47-4da7-80b3-8d982a5c5d22",
      "evidence": "list/bullet: FDA’s sensitivity to potential CNS and hepatic safety signal will now be highly problematic for Harmony.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 1,
      "beatId": "aac0dd07-d17f-4430-b8ac-8dd57ce646ce",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Setup & Stakes",
      "beatSlug": null,
      "evidence": "The document sets up the stakes by presenting the company's troubled history and the concerns over its drug and financial reporting",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}